Should microchimerism turn into rejection prophylactics?

References

• Owen RD. Immunogenetic consequences of vascular anastomoses between bovine twins. Science102, 400 (1945).
   PubMed Web of Science ®Google Scholar
• Billingham RE, Reynolds J. Transplantation studies on sheets of pure epidermal epithelium and on epidermal cell suspensions. Br. J. Plast. Surg.5(1), 25–36 (1952).
   PubMedGoogle Scholar
• Billingham RE, Brent L, Medawar PB. Acquired tolerance of skin homografts. Ann. NY Acad. Sci.59(3), 409–416 (1955).
   Google Scholar
• Monaco AP, Liegeois A, Wood ML. Advances in nephrology. 5, 135–172 (1975).
   Google Scholar
• Monaco AP. Tolerance and chimerism: separate and unequal concepts. Transplant. Proc.34(6), 1991–1997 (2002).
   Google Scholar
• Starzl TE, Demetris AJ, Trucco M et al. Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology17(6), 1127–1152 (1993).
   PubMed Web of Science ®Google Scholar
• Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M. Cell migration, chimerism, and graft acceptance. Lancet339(8809), 1579–1582 (1992).
   PubMed Web of Science ®Google Scholar
• Drexler C, Wagner T. Blood group chimerism. Curr. Opin. Hematol.13(6), 484–489 (2006).
   PubMed Web of Science ®Google Scholar
• Zhong Xy, Holzgreve W, Hahn S. Direct quantification of fetal cells in maternal blood by real-time PCR. Prenat. Diagn.26(9), 850–854 (2006).
   PubMedGoogle Scholar
• Bayes-Genis A, Bellosillo B, De La Calle O et al. Identification of male cardiomyocytes of extracardiac origin in the hearts of women with male progeny: male fetal cell microchimerism of the heart. J. Heart Lung Transplant.24(12), 2179–2183 (2005).
   PubMed Web of Science ®Google Scholar
• Bayes-Genis A, Roura S, Prat-Vidal C et al. Chimerism and microchimerism of the human heart: evidence for cardiac regeneration. Nat. Clin. Pract. Cardiovasc. Med.4(Suppl. 1), S40–S45 (2007).
   Google Scholar
• Piper KP, Mclarnon A, Arrazi J et al. Functional HY-specific CD8+ T cells are found in a high proportion of women following pregnancy with a male fetus. Biol. Reprod.76(1), 96–101 (2007).
   PubMedGoogle Scholar
• Bianchi DW. Fetomaternal cell trafficking: a new cause of disease? Am. J. Med. Genet.91(1), 22–28 (2000).
   PubMed Web of Science ®Google Scholar
• Bianchi DW. Robert E. Gross lecture. Fetomaternal cell trafficking: a story that begins with prenatal diagnosis and may end with stem cell therapy. J. Pediatr. Surg.42(1), 12–18 (2007).
   PubMed Web of Science ®Google Scholar
• Sarkar K, Miller FW. Possible roles and determinants of microchimerism in autoimmune and other disorders. Autoimmun. Rev.3(6), 454–463 (2004).
   PubMed Web of Science ®Google Scholar
• Stevens AM. Microchimeric cells in systemic lupus erythematosus: targets or innocent bystanders? Lupus15(11), 820–826 (2006).
   PubMedGoogle Scholar
• Willer CJ, Herrera BM, Morrison KM, Sadovnick AD, Ebers GC. Association between microchimerism and multiple sclerosis in Canadian twins. J. Neuroimmunol.179(1–2), 145–151 (2006).
   Web of Science ®Google Scholar
• Kremer Hovinga IC, Koopmans M, De Heer E, Bruijn JA, Bajema IM. Chimerism in systemic lupus erythematosus – three hypotheses. Rheumatology (Oxford)46(2), 200–208 (2007).
   PubMed Web of Science ®Google Scholar
• Artlett CM, Miller FW, Rider LG. Persistent maternally derived peripheral microchimerism is associated with the juvenile idiopathic inflammatory myopathies. Rheumatology (Oxford)40(11), 1279–1284 (2001).
   PubMed Web of Science ®Google Scholar
• Reed W, Lee TH, Norris PJ, Utter GH, Busch MP. Transfusion-associated microchimerism: a new complication of blood transfusions in severely injured patients. Semin. Hematol.44(1), 24–31 (2007).
   PubMedGoogle Scholar
• Fast LD. Microchimerism: a lasting legacy of transfusion? Transfusion46(11), 1856–1858 (2006).
   Google Scholar
• Kusaka M, Pratschke J, Wilhelm MJ et al. Activation of inflammatory mediators in rat renal isografts by donor brain death. Transplantation69(3), 405–410 (2000).
   PubMed Web of Science ®Google Scholar
• Takada M, Nadeau KC, Hancock WW et al. Effects of explosive brain death on cytokine activation of peripheral organs in the rat. Transplantation65(12), 1533–1542 (1998).
   PubMed Web of Science ®Google Scholar
• Weiss S, Kotsch K, Francuski M et al. Brain death activates donor organs and is associated with a worse I/R injury after liver transplantation. Am. J. Transplant.7(6), 1584–1593 (2007).
   PubMed Web of Science ®Google Scholar
• Baldwin WM 3rd, Pruitt SK, Brauer RB, Daha MR, Sanfilippo F. Complement in organ transplantation. Contributions to inflammation, injury, and rejection. Transplantation59(6), 797–808 (1995).
   PubMed Web of Science ®Google Scholar
• Hancock WW. Chemokines and transplant immunobiology. J. Am. Soc. Nephrol.13(3), 821–824 (2002).
   PubMedGoogle Scholar
• Hancock WW, Gao W, Faia KL, Csizmadia V. Chemokines and their receptors in allograft rejection. Curr. Opin. Immunol.12(5), 511–516 (2000).
   PubMed Web of Science ®Google Scholar
• Starzl TE, Zinkernagel RM. Antigen localization and migration in immunity and tolerance. N. Engl. J. Med.339(26), 1905–1913 (1998).
   PubMed Web of Science ®Google Scholar
• Starzl TE, Murase N. Microchimerism, macrochimerism, and tolerance. Clin. Transplant.14(4 Pt 1), 351–354 (2000).
   PubMed Web of Science ®Google Scholar
• Reed WF, Lee TL, Trachtenberg E, Vinson M, Busch MP. Detection of microchimerism by PCR is a function of amplification strategy. Transfusion41(1), 39–44 (2001).
   PubMedGoogle Scholar
• Pujal JM, Gallardo D. PCR-based methodology for molecular microchimerism detection and quantification. Exp. Biol. Med. (Maywood)233(9), 1161–1170 (2008).
   PubMedGoogle Scholar
• Frankel W, Chan A, Corringham RE, Shepherd S, Rearden A, Wang-Rodriguez J. Detection of chimerism and early engraftment after allogeneic peripheral blood stem cell or bone marrow transplantation by short tandem repeats. Am. J. Hematol.52(4), 281–287 (1996).
   Google Scholar
• Scharf SJ, Smith AG, Hansen JA, Mcfarland C, Erlich HA. Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers. Blood85(7), 1954–1963 (1995).
   PubMed Web of Science ®Google Scholar
• Hochberg EP, Miklos DB, Neuberg D et al. A novel rapid single nucleotide polymorphism (SNP)-based method for assessment of hematopoietic chimerism after allogeneic stem cell transplantation. Blood101(1), 363–369 (2003).
   PubMed Web of Science ®Google Scholar
• Maas F, Schaap N, Kolen S et al. Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphisms. Leukemia17(3), 630–633 (2003).
   Google Scholar
• Alizadeh M, Bernard M, Danic B et al. Quantitative assessment of hematopoietic chimerism after bone marrow transplantation by real-time quantitative polymerase chain reaction. Blood99(12), 4618–4625 (2002).
   PubMed Web of Science ®Google Scholar
• Garavito G, Klein D, Denis M, Pugliese A, Ricordi C, Pastori RL. Real-time sequence-specific primer polymerase chain reaction amplification of HLA class II alleles: a novel approach to analyze microchimerism. Transplantation73(5), 822–825 (2002).
   PubMedGoogle Scholar
• Spriewald BM, Wassmuth R, Carl HD et al. Microchimerism after liver transplantation: prevalence and methodological aspects of detection. Transplantation66(1), 77–83 (1998).
   Google Scholar
• Lambert NC, Erickson TD, Yan Z et al. Quantification of maternal microchimerism by HLA-specific real-time polymerase chain reaction: studies of healthy women and women with scleroderma. Arthritis Rheum.50(3), 906–914 (2004).
   PubMed Web of Science ®Google Scholar
• Pezzoli N, Silvy M, Woronko A et al. Quantification of mixed chimerism by real time PCR on whole blood-impregnated FTA cards. Leuk. Res.31(9), 1175–1183 (2007).
   Google Scholar
• Kristt D, Stein J, Yaniv I, Klein T. Assessing quantitative chimerism longitudinally: technical considerations, clinical applications and routine feasibility. Bone Marrow Transplant39(5), 255–268 (2007).
   PubMedGoogle Scholar
• Bai L, Deng YM, Dodds AJ, Milliken S, Moore J, Ma DD. A sybr green-based real-time PCR method for detection of haemopoietic chimerism in allogeneic haemopoietic stem cell transplant recipients. Eur. J. Haematol.77(5), 425–431 (2006).
   Google Scholar
• Buno I, Nava P, Simon A et al. A comparison of fluorescent in situ hybridization and multiplex short tandem repeat polymerase chain reaction for quantifying chimerism after stem cell transplantation. Haematologica90(10), 1373–1379 (2005).
   PubMed Web of Science ®Google Scholar
• Dubernard Jm, Lengele B, Morelon E et al. Outcomes 18 months after the first human partial face transplantation. N. Engl. J. Med.357(24), 2451–2460 (2007).
   PubMed Web of Science ®Google Scholar
• Costa JM, Benachi A, Gautier E, Jouannic JM, Ernault P, Dumez Y. First-trimester fetal sex determination in maternal serum using real-time PCR. Prenat. Diagn.21(12), 1070–1074 (2001).
   Google Scholar
• Hromadnikova I, Houbova B, Hridelova D et al. Replicate real-time PCR testing of DNA in maternal plasma increases the sensitivity of non-invasive fetal sex determination. Prenat. Diagn.23(3), 235–238 (2003).
   PubMed Web of Science ®Google Scholar
• Pujal JM, Grinyo JM, Gil-Vernet S et al. Early hematopoietic microchimerism predicts clinical outcome after kidney transplantation. Transplantation84(9), 1103–1111 (2007).
   PubMedGoogle Scholar
• Ko S, Deiwick A, Dinkel A, Wonigeit K, Schlitt HJ. Functional relevance of donor-derived hematopoietic microchimerism only for induction but not for maintenance of allograft acceptance. Transplant. Proc.31(1–2), 920–921 (1999).
   Google Scholar
• Sahota A, Gao S, Hayes J, Jindal RM. Microchimerism and rejection: a meta-analysis. Clin. Transplant.14(4 Pt 1), 345–350 (2000).
   PubMed Web of Science ®Google Scholar
• Shirwan H, Wu GD, Barwari L, Liu A, Cramer DV. Induction of allograft nonresponsiveness after intrathymic inoculation with donor class I allopeptides. II. Evidence for persistent chronic rejection despite high levels of donor microchimerism. Transplantation64(12), 1671–1676 (1997).
   Google Scholar
• Domiati-Saad R, Klintmalm GB, Netto G, Agura ED, Chinnakotla S, Smith DM. Acute graft versus host disease after liver transplantation: patterns of lymphocyte chimerism. Am. J. Transplant.5(12), 2968–2973 (2005).
   PubMed Web of Science ®Google Scholar
• Calne R, Davies H. Organ graft tolerance: the liver effect. Lancet343(8889), 67–68 (1994).
   PubMed Web of Science ®Google Scholar
• Benseler V, Mccaughan GW, Schlitt HJ, Bishop GA, Bowen DG, Bertolino P. The liver: a special case in transplantation tolerance. Semin. Liver Dis.27(2), 194–213 (2007).
   PubMed Web of Science ®Google Scholar
• Starzl TE, Lakkis FG. The unfinished legacy of liver transplantation: emphasis on immunology. Hepatology43(2 Suppl. 1), S151–S163 (2006).
   Google Scholar
• Larsen CP, Morris PJ, Austyn JM. Migration of dendritic leukocytes from cardiac allografts into host spleens. A novel pathway for initiation of rejection. J. Exp. Med.171(1), 307–314 (1990).
   PubMed Web of Science ®Google Scholar
• Austyn JM, Larsen CP. Migration patterns of dendritic leukocytes. Implications for transplantation. Transplantation49(1), 1–7 (1990).
   PubMed Web of Science ®Google Scholar
• Kupiec-Weglinski JW, Austyn JM, Morris PJ. Migration patterns of dendritic cells in the mouse. Traffic from the blood, and T cell-dependent and -independent entry to lymphoid tissues. J. Exp. Med.167(2), 632–645 (1988).
   PubMed Web of Science ®Google Scholar
• Caillat-Zucman S, Legendre C, Suberbielle C et al. Microchimerism frequency two to thirty years after cadaveric kidney transplantation. Hum. Immunol.41(1), 91–95 (1994).
   PubMed Web of Science ®Google Scholar
• Suberbielle C, Caillat-Zucman S, Legendre C et al. Peripheral microchimerism in long-term cadaveric-kidney allograft recipients. Lancet343(8911), 1468–1469 (1994).
   PubMedGoogle Scholar
• Strober S, Benike C, Krishnaswamy S, Engleman EG, Grumet FC. Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity. Transplantation69(8), 1549–1554 (2000).
   PubMedGoogle Scholar
• Vanbuskirk AM, Burlingham WJ, Jankowska-Gan E et al. Human allograft acceptance is associated with immune regulation. J. Clin. Invest.106(1), 145–155 (2000).
   PubMed Web of Science ®Google Scholar
• Hisanaga M, Hundrieser J, Boker K et al. Development, stability, and clinical correlations of allogeneic microchimerism after solid organ transplantation. Transplantation61(1), 40–45 (1996).
   Google Scholar
• Devlin J, Doherty D, Thomson L et al. Defining the outcome of immunosuppression withdrawal after liver transplantation. Hepatology27(4), 926–933 (1998).
   PubMed Web of Science ®Google Scholar
• Mcdaniel HB, Yang M, Sidner RA, Jindal RM, Sahota A. Prospective study of microchimerism in transplant recipients. Clin. Transplant.13(2), 187–192 (1999).
   Google Scholar
• Sivasai KS, Alevy YG, Duffy BF et al. Peripheral blood microchimerism in human liver and renal transplant recipients: rejection despite donor-specific chimerism. Transplantation64(3), 427–432 (1997).
   PubMedGoogle Scholar
• Elwood ET, Larsen CP, Maurer DH et al. Microchimerism and rejection in clinical transplantation. Lancet349(9062), 1358–1360 (1997).
   PubMedGoogle Scholar
• Reinsmoen NL, Jackson A, Hertz M et al. Peripheral blood allogeneic microchimerism in lung and cardiac allograft recipients. J. Leukoc. Biol.66(2), 306–309 (1999).
   Google Scholar
• Billingham RE, Brent L, Medawar PB. Activity acquired tolerance of foreign cells. Nature172(4379), 603–606 (1953).
   PubMed Web of Science ®Google Scholar
• Anderson D, Billingham ME, Lampkin GH, Medawar PB. The use of skin grafting to distinguish between monozygotic and dizygotic twins in cattle. Heredity (5), 379 (1951).
   Google Scholar
• Parry SL, Hall FC, Olson J, Kamradt T, Sonderstrup G. Autoreactivity versus autoaggression: a different perspective on human autoantigens. Curr. Opin. Immunol.10(6), 663–668 (1998).
   PubMed Web of Science ®Google Scholar
• Rovere-Querini P, Manfredi AA, Sabbadini MG. Environmental adjuvants, apoptosis and the censorship over autoimmunity. Autoimmun. Rev.4(8), 555–560 (2005).
   PubMed Web of Science ®Google Scholar
• Starzl TE, Demetris AJ, Trucco M et al. Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation. Transplantation55(6), 1272–1277 (1993).
   PubMedGoogle Scholar
• Bonasio R, Scimone ML, Schaerli P, Grabie N, Lichtman AH, Von Andrian UH. Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus. Nat. Immunol.7(10), 1092–1100 (2006).
   Google Scholar
• Duncan SR, Capetanakis NG, Lawson BR, Theofilopoulos AN. Thymic dendritic cells traffic to thymi of allogeneic recipients and prolong graft survival. J. Clin. Invest.109(6), 755–764 (2002).
   PubMedGoogle Scholar
• Ochando JC, Homma C, Yang Y et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat. Immunol.7(6), 652–662 (2006).
   PubMed Web of Science ®Google Scholar
• Taniguchi H, Toyoshima T, Fukao K, Nakauchi H. Presence of hematopoietic stem cells in the adult liver. Nat. Med.2(2), 198–203 (1996).
   PubMed Web of Science ®Google Scholar
• Tajik N, Singal D, Pourmand G et al. Prospective study of microchimerism in renal allograft recipients: association between HLA-DR matching, microchimerism and acute rejection. Clin. Transplant.15(3), 192–198 (2001).
   Google Scholar
• Sykes M, Sachs DH. Bone marrow transplantation as a means of inducing tolerance. Semin. Immunol.2(6), 401–417 (1990).
   PubMedGoogle Scholar
• Murase N, Starzl TE, Tanabe M et al. Variable chimerism, graft-versus-host disease, and tolerance after different kinds of cell and whole organ transplantation from lewis to brown norway rats. Transplantation60(2), 158–171 (1995).
   Google Scholar
• Thomson Aw, Lu L, Murase N, Demetris AJ, Rao AS, Starzl TE. Microchimerism, dendritic cell progenitors and transplantation tolerance. Stem Cells13(6), 622–639 (1995).
   Google Scholar
• Ehl S, Aichele P, Ramseier H et al. Antigen persistence and time of T-cell tolerization determine the efficacy of tolerization protocols for prevention of skin graft rejection. Nat. Med.4(9), 1015–1019 (1998).
   Google Scholar
• Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu. Rev. Immunol.21, 685–711 (2003).
   PubMed Web of Science ®Google Scholar
• Bonilla WV, Geuking MB, Aichele P, Ludewig B, Hengartner H, Zinkernagel RM. Microchimerism maintains deletion of the donor cell-specific CD8+ T cell repertoire. J. Clin. Invest.116(1), 156–162 (2006).
   PubMedGoogle Scholar
• Kiyomoto T, Toyokawa H, Nakao A et al. The difficulty of eliminating donor leukocyte microchimerism in rat recipients bearing established organ allografts. Transplantation81(3), 438–444 (2006).
   Google Scholar
• Shirwan H, Wang HK, Barwari L, Makowka L, Cramer DV. Pretransplant injection of allograft recipients with donor blood or lymphocytes permits allograft tolerance without the presence of persistent donor microchimerism. Transplantation61(9), 1382–1386 (1996).
   PubMedGoogle Scholar
• Kawai T, Wee SL, Bazin H et al. Association of natural killer cell depletion with induction of mixed chimerism and allograft tolerance in non-human primates. Transplantation70(2), 368–374 (2000).
   Google Scholar
• Hamano K, Rawsthorne MA, Bushell AR, Morris PJ, Wood KJ. Evidence that the continued presence of the organ graft and not peripheral donor microchimerism is essential for maintenance of tolerance to alloantigen in vivo in anti-CD4 treated recipients. Transplantation62(6), 856–860 (1996).
   PubMed Web of Science ®Google Scholar
• Wekerle T, Blaha P, Koporc Z, Bigenzahn S, Pusch M, Muehlbacher F. Mechanisms of tolerance induction through the transplantation of donor hematopoietic stem cells: central versus peripheral tolerance. Transplantation75(9 Suppl.), S21–S25 (2003).
   Google Scholar
• Van Pel M, Van Breugel DW, Van Wijk M et al. Donor-specific tolerance in a murine model: the result of extra-thymic T cell deletion? Transplant. Immunol.11(3–4), 375–384 (2003).
   Google Scholar
• Ramsdell F, Fowlkes BJ. Maintenance of in vivo tolerance by persistence of antigen. Science257(5073), 1130–1134 (1992).
   PubMed Web of Science ®Google Scholar
• Monaco AP. Prospects and strategies for clinical tolerance. Transplant. Proc.36(1), 227–231 (2004).
   PubMed Web of Science ®Google Scholar
• Sykes M. Mechanisms of tolerance induced via mixed chimerism. Front. Biosci.12, 2922–2934 (2007).
   PubMed Web of Science ®Google Scholar
• Guo K, Inaba M, Li M et al. Long-term donor-specific tolerance in rat cardiac allografts by intrabone marrow injection of donor bone marrow cells. Transplantation85(1), 93–101 (2008).
   Google Scholar
• Karim M, Steger U, Bushell AR, Wood KJ. The role of the graft in establishing tolerance. Front. Biosci.7, E129–E154 (2002).
   Google Scholar
• Gassel HJ, Otto C, Klein I et al. Persistence of stable intragraft cell chimerism in rat liver allografts after drug-induced tolerance. Transplantation71(12), 1848–1852 (2001).
   Google Scholar
• Adler SH, Turka LA. Immunotherapy as a means to induce transplantation tolerance. Curr. Opin. Immunol.14(5), 660–665 (2002).
   Google Scholar
• Nemlander A, Soots A, Von Willebrand E, Husberg B, Hayry P. Redistribution of renal allograft-responding leukocytes during rejection. II. Kinetics and specificity. J. Exp. Med.156(4), 1087–1100 (1982).
   Google Scholar
• Demetris Aj, Qian S, Sun H et al. Early events in liver allograft rejection. Delineation of sites of simultaneous intragraft and recipient lymphoid tissue sensitization. Am. J. Pathol.138(3), 609–618 (1991).
   Google Scholar
• Murase N, Demetris AJ, Woo J et al. Graft-versus-host disease after brown norway-to-lewis and lewis-to-brown norway rat intestinal transplantation under fk506. Transplantation55(1), 1–7 (1993).
   Google Scholar
• Demetris AJ, Murase N, Fujisaki S, Fung JJ, Rao AS, Starzl TE. Hematolymphoid cell trafficking, microchimerism, and GVH reactions after liver, bone marrow, and heart transplantation. Transplant. Proc.25(6), 3337–3344 (1993).
   Google Scholar
• Terakura M, Murase N, Demetris AJ, Ye Q, Thomson AW, Starzl TE. Lymphoid/nonlymphoid compartmentalization of donor leukocyte chimerism in rat recipients of heart allografts, with or without adjunct bone marrow. Transplantation66(3), 350–357 (1998).
   Google Scholar
• Sakamoto T, Ye Q, Lu L, Demetris AJ, Starzl TE, Murase N. Donor hematopoietic progenitor cells in nonmyeloablated rat recipients of allogeneic bone marrow and liver grafts. Transplantation67(6), 833–840 (1999).
   Google Scholar
• Ichikawa N, Demetris AJ, Starzl TE et al. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: With particular reference to chronic rejection. Liver Transplant.6(6), 686–702 (2000).
   Google Scholar
• Kawai T, Cosimi AB, Spitzer TR et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N. Engl. J. Med.358(4), 353–361 (2008).
   PubMed Web of Science ®Google Scholar
• Manilay JO, Pearson DA, Sergio JJ, Swenson KG, Sykes M. Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen. Transplantation66(1), 96–102 (1998).
   PubMed Web of Science ®Google Scholar
• Tomita Y, Khan A, Sykes M. Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a nonmyeloablative regimen. J. Immunol.153(3), 1087–1098 (1994).
   PubMedGoogle Scholar
• Khan A, Tomita Y, Sykes M. Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance. Transplantation62(3), 380–387 (1996).
   PubMedGoogle Scholar
• Sykes M. Mixed chimerism and transplant tolerance. Immunity14(4), 417–424 (2001).
   PubMed Web of Science ®Google Scholar
• Salgar SK, Shapiro R, Dodson F et al. Infusion of donor leukocytes to induce tolerance in organ allograft recipients. J. Leukoc. Biol.66(2), 310–314 (1999).
   Google Scholar
• Garcia-Morales R, Carreno M, Mathew J et al. Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients. Transplantation65(7), 956–965 (1998).
   PubMedGoogle Scholar
• Garcia-Morales R, Carreno M, Mathew J et al. The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients. J. Clin. Invest.99(5), 1118–1129 (1997).
   PubMed Web of Science ®Google Scholar
• Ciancio G, Burke GW, Moon J et al. Donor bone marrow infusion in deceased and living donor renal transplantation. Yonsei Med. J.45(6), 998–1003 (2004).
   Google Scholar
• Ciancio G, Miller J, Garcia-Morales RO et al. Six-year clinical effect of donor bone marrow infusions in renal transplant patients. Transplantation71(7), 827–835 (2001).
   PubMed Web of Science ®Google Scholar
• Millan MT, Shizuru JA, Hoffmann P et al. Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation73(9), 1386–1391 (2002).
   PubMed Web of Science ®Google Scholar
• Lubaroff DM, Silvers WK. Importance of chimerism in maintaining tolerance of skin allografts in mice. J. Immunol.111(1), 65–71 (1973).
   Google Scholar
• Cai J, Lee J, Jankowska-Gan E et al. Minor H antigen HA-1-specific regulator and effector CD8+ T cells, and HA-1 microchimerism, in allograft tolerance. J. Exp. Med.199(7), 1017–1023 (2004).
   PubMed Web of Science ®Google Scholar
• Girlanda R, Rela M, Williams R, O’Grady JG, Heaton ND. Long-term outcome of immunosuppression withdrawal after liver transplantation. Transplant. Proc.37(4), 1708–1709 (2005).
   PubMed Web of Science ®Google Scholar
• Wood K, Sachs DH. Chimerism and transplantation tolerance: cause and effect. Immunol. Today17(12), 584–587; discussion 588 (1996).
   PubMedGoogle Scholar
• Cosimi AB, Sachs DH. Mixed chimerism and transplantation tolerance. Transplantation77(6), 943–946 (2004).
   PubMedGoogle Scholar
• Buhler LH, Spitzer TR, Sykes M et al. Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation74(10), 1405–1409 (2002).
   PubMed Web of Science ®Google Scholar
• Bunce M, O’Neill CM, Barnardo MC et al. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens46(5), 355–367 (1995).
   PubMed Web of Science ®Google Scholar
• Claas F. Chimerism as a tool to induce clinical transplantation tolerance. Curr. Opin. Immunol.16(5), 578–583 (2004).
   PubMed Web of Science ®Google Scholar
• Adams DH, Hutchinson IV. Microchimerism and graft tolerance: cause or effect? Lancet349(9062), 1336–1337 (1997).
   PubMed Web of Science ®Google Scholar
• Redmond WL, Marincek BC, Sherman LA. Distinct requirements for deletion versus anergy during CD8 T cell peripheral tolerance in vivo. J. Immunol.174(4), 2046–2053 (2005).
   Web of Science ®Google Scholar
• Walker LS, Abbas AK. The enemy within: Keeping self-reactive T cells at bay in the periphery. Nat. Rev. Immunol.2(1), 11–19 (2002).
   PubMed Web of Science ®Google Scholar
• Wood KJ, Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol.3(3), 199–210 (2003).
   PubMed Web of Science ®Google Scholar
• Hernandez J, Aung S, Redmond WL, Sherman LA. Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J. Exp. Med.194(6), 707–717 (2001).
   PubMed Web of Science ®Google Scholar
• Heath WR, Carbone FR. Cross-presentation, dendritic cells, tolerance and immunity. Annu. Rev. Immunol.19, 47–64 (2001).
   PubMed Web of Science ®Google Scholar
• Kurtz J, Wekerle T, Sykes M. Tolerance in mixed chimerism – a role for regulatory cells? Trends Immunol.25(10), 518–523 (2004).
   Web of Science ®Google Scholar
• Quaini F, Urbanek K, Beltrami AP et al. Chimerism of the transplanted heart. N. Engl. J. Med.346(1), 5–15 (2002).
   PubMed Web of Science ®Google Scholar
• Lagaaij EL, Cramer-Knijnenburg GF, Van Kemenade FJ, Van Es LA, Bruijn JA, Van Krieken JH. Endothelial cell chimerism after renal transplantation and vascular rejection. Lancet357(9249), 33–37 (2001).
   PubMedGoogle Scholar
• Nankivell BJ, Borrows RJ, Fung CL, O’Connell PJ, Allen RD, Chapman JR. Natural history, risk factors, and impact of subclinical rejection in kidney transplantation. Transplantation78(2), 242–249 (2004).
   PubMed Web of Science ®Google Scholar
• Nankivell BJ, Borrows RJ, Fung CL, O’Connell PJ, Allen RD, Chapman JR. The natural history of chronic allograft nephropathy. N. Engl. J. Med.349(24), 2326–2333 (2003).
   PubMedGoogle Scholar
• Ashto J, Giral M, Brouard S, Soulillou JP. Spontaneous operational tolerance after immunosuppressive drug withdrawal in clinical renal allotransplantation. Transplantation84(10), 1215–1219 (2007).
   Google Scholar
• Louis S, Braudeau C, Giral M et al. Contrasting CD25HICD4+T cells/FOXP3 patterns in chronic rejection and operational drug-free tolerance. Transplantation81(3), 398–407 (2006).
   PubMed Web of Science ®Google Scholar
• Braudeau C, Racape M, Giral M et al. Variation in numbers of CD4+CD25highFOXP3+ T cells with normal immuno-regulatory properties in long-term graft outcome. Transpl. Int.20(10), 845–855 (2007).
   Google Scholar